Article
Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer
13 Jan 2021
Abstract excerpt
Despite great advances in our understanding of the pathobiology of colorectal cancer and the genetic and environmental factors that mitigate its onset and progression, a paucity of effective treatments persists. The five-year survival for advanced, stage IV disease remains substantially less than 20%. This review examines a relatively untapped reservoir of potential therapies to target muscarinic receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
